THANK YOU FOR SUBSCRIBING
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
AQUACEL® Ag SURGICAL cover dressings significantly demonstrated the ability to reduce the incidence of post-operative infection and other complications, such as skin blistering, and improve patient satisfaction. In a retrospective clinical study of 1,778 patients undergoing hip and knee replacement surgery (total joint arthroplasty or "TJA"), published in The Journal of Arthroplasty, the use of AQUACEL® Ag Surgical cover dressing vs. standard gauze surgical dressing reduced periprosthetic joint infection ("PJI") by 76 percent (0.4% vs. 1.7%, p=0.005).![]()
The innovative design of AQUACEL® Ag SURGICAL cover dressings has been proven to handle post-operative challenges
Share this Article:
Tweet
|
Company
ConvaTec
Headquarters
Deeside, United Kingdom
Management
Michael Steadman, President
Description
ConvaTec is a global medical device and technologies company focused on therapies for the management of acute and chronic wounds. Featuring the ConvaTec patented Hydrofiber® Technology combined with skin-friendly hydrocolloid technology, AQUACEL® Ag SURGICAL cover dressings are supported by evidence showing significant reduction in the incidence of superficial surgical site infection (SSI), skin blistering and delayed discharge as compared to a non-woven post-operative surgical cover dressing regimen.1a, 2b The unique construction ofAQUACEL® Ag SURGICAL cover dressings provides a waterproof, viral and bacterial barrier* that allows for flexibility and extensibility during body movement
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info